Citation: M. John et al., HEPATITIS-C VIRUS-ASSOCIATED HEPATITIS FOLLOWING TREATMENT OF HIV-INFECTED PATIENTS WITH HIV PROTEASE INHIBITORS - AN IMMUNE RESTORATION DISEASE, AIDS, 12(17), 1998, pp. 2289-2293
Citation: Jp. Pandey et Mah. French, GM PHENOTYPES INFLUENCE THE CONCENTRATIONS OF THE 4 SUBCLASSES OF IMMUNOGLOBULIN-G IN NORMAL HUMAN SERUM, Human immunology, 51(2), 1996, pp. 99-102
Citation: Mr. Segal et al., STATISTICAL ISSUES IN THE EVALUATION OF MARKERS OF HIV PROGRESSION, International statistical review, 63(2), 1995, pp. 179-197
Citation: Jr. Dyer et al., CEREBRAL MASS LESIONS DUE TO CYTOMEGALOVIRUS IN PATIENTS WITH AIDS - REPORT OF 2 CASES, The Journal of infection, 30(2), 1995, pp. 147-151
Citation: Mah. French et al., SEVERITY OF INFECTIONS IN IGA DEFICIENCY - CORRELATION WITH DECREASEDSERUM ANTIBODIES TO PNEUMOCOCCAL POLYSACCHARIDES AND DECREASED SERUM IGG2 AND OR IGG4/, Clinical and experimental immunology, 100(1), 1995, pp. 47-53
Authors:
MALLAL SA
MARTINEZ OP
FRENCH MAH
JAMES IR
DAWKINS RL
Citation: Sa. Mallal et al., SEVERITY AND OUTCOME OF PNEUMOCYSTIS-CARINII PNEUMONIA (PCP) IN PATIENTS OF KNOWN AND UNKNOWN HIV STATUS, Journal of acquired immune deficiency syndromes, 7(2), 1994, pp. 148-153
Citation: Sa. Mallal et al., DETECTION OF SUBCLINICAL MYCOBACTERIUM-AVIUM-INTRACELLULARE COMPLEX INFECTION IN IMMUNODEFICIENT HIV-INFECTED PATIENTS TREATED WITH ZIDOVUDINE, AIDS, 8(9), 1994, pp. 1263-1269